Showing results (261-270 of 315) with videos related to
Sort By:
Pageof 32
Gynecologic Oncology|June 1, 1995
A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904K S Albain, P Y Liu, A Hantel, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.Journal of the National Cancer Institute|August 1, 1990
Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancersD S Alberts, J Einspahr, S Rees-McGee, et al.Clinical Pharmacology and Therapeutics|July 1, 1979
Kinetics of intravenous melphalanD S Alberts, S Y Chang, H S Chen, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1994
Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cellsL J Hixson, D S Alberts, M Krutzsch, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 17, 2007
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancerL M Hess, M Benham-Hutchins, T J Herzog, et al.Investigational New Drugs|January 1, 1990
A phase I and pharmacokinetic study of intravenous vinzolidineC W Taylor, S E Salmon, W G Satterlee, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity studyG Tricot, D S Alberts, C Johnson, et al.Cancer Research|October 28, 1999
Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomasM E Martínez, T Maltzman, J R Marshall, et al.Pageof 32